Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 47 non-cytoplasmic 48 70 transmembrane 71 91 cytoplasmic 92 114 transmembrane 115 126 non-cytoplasmic 127 145 transmembrane 146 154 cytoplasmic 155 176 transmembrane 177 195 non-cytoplasmic 196 215 transmembrane 216 235 cytoplasmic 236 255 transmembrane 256 288 non-cytoplasmic 289 312 transmembrane 313 332 cytoplasmic 333 353 transmembrane 354 361 non-cytoplasmic 362 383 transmembrane 384 394 cytoplasmic 395 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 449 cytoplasmic
Input: >Pf1N1B4_5855 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_5855 MEIEEFGYKQELKRSLSLTDLVVYGMIFMIPIAPFGVYGYVNAEAPGMVPLAYIIGMVAM LFTALSYGSMARAFPIAGSVYSYAQRGLNPHVGFIAGWLMLLDYLLIPPLLYVYAAMALN HLYPDIPKVGFILAFLVSATFVNLRGITFTARMNIVFLLAQLVVLGIFLFYAWNALHSGG GNGQLTLAPLYNPETFNFALLMQAVSIAVLSFLGFDAISTLAEEIKGDPGRSVGKAALIT LLVMGVIFVVQTWIATDLAAGLGFKSADTAFYEIAEIAAGSWLATLTAVATALAWGVAVA ITSQAAVSRLLFGMARDGKLPKVLAKVHPKHNTPYLSIYLVAVLSLVICYLFINSVDTLT SLVNFGALSGFMLLHLTVINYYWRRQKSGQVIRHLICPVIGFIIVAAIMYNMGVDAQKLG LIWIALGLVYLFFLNKLGASTALPDPSNG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server